MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hep.30578

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2019

The Spectrum of Hepatic Involvement in Patients With Telomere Disease.

Kapuria Devika, Ben-Yakov Gil, Ortolano Rebecca, Cho Min Ho, Kalchiem-Dekel Or, Takyar Varun, Lingala Shilpa, Gara Naveen, Tana Michele, Kim Yun Ju, Kleiner David E, Young Neal S, Townsley Danielle M, Koh Christopher, Heller Theo

СтатьяПеревод в очереди

Аннотация

Loss-of-function mutations in genes that encode for components of the telomere repair complex cause accelerated telomere shortening. Hepatic involvement has been recognized as a cause of morbidity in telomere diseases, but very few studies have characterized the nature and extent of liver involvement in affected patients. We report the prevalence and characteristics of liver involvement in a large cohort of patients with telomere disease evaluated serially at the National Institutes of Health. One hundred twenty-one patients with known or suspected telomere disease were screened; 40 patients with liver involvement were included in the current study. Median follow-up was 2.4 years. Data were collected regarding their demographic information, laboratory analysis, imaging, and histopathology. Forty patients (40% of the cohort) with a median age of 42 years were found to have liver involvement. Liver enzyme elevation was cholestatic in pattern; 8 (21%) had drug-related enzyme elevations. The most common imaging finding was increased hepatic echogenicity on ultrasound in 39% (9) of patients, followed by hepatomegaly in 26% (6). Biopsies were infrequent because of risk associated with thrombocytopenia, but in 6 patients, there were varying findings: nodular regenerative hyperplasia, steatohepatitis, hemosiderosis, cholestasis, and cirrhosis with hepatic steatosis. Almost half the cohort had pulmonary diffusion abnormalities, and 25% died during the follow-up period.

Conclusion

In patients with telomere disease, hepatic involvement is common and can present in diverse ways, including elevated liver enzymes as well as histopathologic and imaging abnormalities. Liver disease has important implications for morbidity and mortality in patients with telomere disease.

Для цитирования: Kapuria Devika, Ben-Yakov Gil, Ortolano Rebecca, Cho Min Ho, Kalchiem-Dekel Or, Takyar Varun, Lingala Shilpa, Gara Naveen, Tana Michele, Kim Yun Ju, Kleiner David E, Young Neal S, Townsley Danielle M, Koh Christopher, Heller Theo. The Spectrum of Hepatic Involvement in Patients With Telomere Disease.. Hepatology (Baltimore, Md.). 2019. DOI: 10.1002/hep.30578.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.